{
  "content": "1V. Fuster, L.E. Ryden, R.W. Asinger, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology  Circulation, 104 (2001), pp. 2118-2150 View in ScopusGoogle Scholar",
  "source": "https://www.sciencedirect.com/science/article/pii/S0735109702027055",
  "chunk_id": "ea84128f-cdab-4457-b8d2-3c23bedbe9bd",
  "similarity_score": 0.35919827222824097,
  "query": "atrial fibrillation guidelines ESC AHA CCS amiodarone beta-blockers recommendations clinical practice first-line therapy",
  "rank": 29,
  "title": "Amiodarone versus placebo and class ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis",
  "authors": "Philippe Chevalier, Alexis Durand-Dubief, Haran Burri, Michel Cucherat, Gilbert Kirkorian, Paul Touboul",
  "year": "2003",
  "journal": "Journal of the American College of Cardiology",
  "reference": "Chevalier, P., Durand-Dubief, A., Burri, H., Cucherat, M., Kirkorian, G., & Touboul, P. (2003). Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: A meta-analysis. Journal of the American College of Cardiology, 41(2), 255-262.",
  "doi": "Not available",
  "chunk_index": 51,
  "total_chunks": 77,
  "retrieved_at": "2025-07-24T21:58:06.270562"
}